help button home button Am J Pathol Epitomics Buy 2 Antibodies Get 1 Free Special Offer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reifenberger, J.
Right arrow Articles by Collins, V. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reifenberger, J.
Right arrow Articles by Collins, V. P.

American Journal of Pathology, Vol 149, 29-35, Copyright © 1996 by American Society for Investigative Pathology


REGULAR ARTICLES

Epidermal growth factor receptor expression in oligodendroglial tumors

J Reifenberger, G Reifenberger, K Ichimura, EE Schmidt, W Wechsler and VP Collins
Department of Neuropathology, Heinrich-Heine-University, Dusseldorf, Germany.

A series of 13 oligodendrogliomas (WHO grade II) and 20 anaplastic oligodendrogliomas (WHO grade III) was studied for gene amplification and expression of the epidermal growth factor receptor gene (EGFR). EGFR gene amplification was found in only one case of anaplastic oligodendroglioma, which additionally showed a deletion/rearrangement at the 5' end of the gene. Northern blot analysis, however, revealed increases of EGFR mRNA expression relative to non-neoplastic control brain in 6 of 13 oligodendrogliomas and 10 of 18 anaplastic oligodendrogliomas. All cases with increased mRNA expression showed strong immunoreactivity for EGFR protein. Our findings thus indicate that increased expression of EGFR mRNA and protein is common in low- grade and high-grade oligodendroglial tumors and in the vast majority of cases is not caused by gene amplification.


This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
M. K. Nicholas, R. V. Lukas, N. F. Jafri, L. Faoro, and R. Salgia
Epidermal Growth Factor Receptor-Mediated Signal Transduction in the Development and Therapy of Gliomas
Clin. Cancer Res., December 15, 2006; 12(24): 7261 - 7270.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
W. A. Weiss, M. J. Burns, C. Hackett, K. Aldape, J. R. Hill, H. Kuriyama, N. Kuriyama, N. Milshteyn, T. Roberts, M. F. Wendland, et al.
Genetic Determinants of Malignancy in a Mouse Model for Oligodendroglioma
Cancer Res., April 1, 2003; 63(7): 1589 - 1595.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
K. Hoang-Xuan, J. He, S. Huguet, K. Mokhtari, Y. Marie, M. Kujas, P. Leuraud, L. Capelle, J. Y. Delattre, J. Poirier, et al.
Molecular heterogeneity of oligodendrogliomas suggests alternative pathways in tumor progression
Neurology, October 9, 2001; 57(7): 1278 - 1281.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
R. E. McLendon, C. J. Wikstrand, M. R. Matthews, R. Al-Baradei, S. H. Bigner, and D. D. Bigner
Glioma-associated Antigen Expression in Oligodendroglial Neoplasms: Tenascin and Epidermal Growth Factor Receptor
J. Histochem. Cytochem., August 1, 2000; 48(8): 1103 - 1110.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the American Society for Investigative Pathology.